This study is looking at the long-term effects of CBL-514 Injection for reducing subcutaneous fat (fat under the skin). It's also comparing CBL-514 to a placebo (0.9% sodium chloride, a salt water solution). You may be able to join if you've already received CBL-514 or placebo in a previous study and completed a follow-up visit. The main goal is to see how many participants experience side effects over 6, 9, and 12 months after their last treatment in the earlier studies. The study aims to enroll about 300 adults, but its current status is unclear.

Study design

This is a Phase 3b, double-blind (meaning neither you nor your doctor will know if you received CBL-514 or placebo), long-term follow-up and open-label extension study involving about 300 participants.

What's involved

You would have three follow-up visits, scheduled every three months, after completing a previous study.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 6, 9, and 12 months after their last treatment in the parent studies to check for side effects.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.